This inventor holds 3 USPTO granted patents. Top assignees: Connaught Laboratories Limited, Aventis Pasteur Limited. Active years: 1997-2001.
Company Filing History:
Years Active: 1997-2001
Title: Lucy Gisonni: Innovator in Immunogenic Conjugate Molecules
Introduction
Lucy Gisonni is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of immunology, particularly through her development of immunogenic conjugate molecules. With a total of three patents to her name, Gisonni's work focuses on enhancing the efficacy of vaccines against certain bacterial pathogens.
Latest Patents
Gisonni's latest patents include innovative immunogenic conjugate molecules. These molecules comprise a portion of a capsular polysaccharide derived from a Streptococcus strain, which is linked to an outer membrane protein from a Haemophilus strain. This unique combination aims to enhance the immunogenicity of the capsular polysaccharides, making the vaccines more effective in eliciting an immune response. Specifically, her patents describe the use of outer membrane proteins P1, P2, and particularly P6, to create these conjugate molecules. Additionally, these components may be utilized in diagnostic procedures and kits, addressing diseases caused by these strains.
Career Highlights
In her professional journey, Lucy Gisonni has made valuable contributions while working for renowned organizations such as Connaught Laboratories Limited and Aventis Pasteur Limited. Her work in these companies has not only allowed her to innovate but also to significantly influence the landscape of immunology.
Collaborations
Throughout her career, Gisonni has collaborated with esteemed colleagues, including Yan-Ping Yang and Ali Kandil. These collaborations have been instrumental in advancing her research and achieving breakthroughs in the field of immunogenic conjugates.
Conclusion
With her innovative spirit and dedication to scientific advancement, Lucy Gisonni continues to impact the field of immunology through her inventions. Her patents serve as a testament to her commitment to enhancing vaccine effectiveness and improving public health outcomes. As she progresses in her career, the scientific community eagerly anticipates her future contributions.